8th HPAPI: Development and Manufacturing of Highly Potent Active Pharmaceutical Ingredients (APIs)

8th HPAPI Summit Brings Industry Experts Together in Berlin to Explore Highly Potent API Development and Manufacturing

The 8th HPAPI: Development and Manufacturing of Highly Potent Active Pharmaceutical Ingredients Summit brought together industry professionals in Berlin in 2025 for two days of knowledge exchange, technical discussion and professional networking.

The summit provided a focused platform to explore the challenges and opportunities surrounding highly potent API development, manufacturing and safe handling. The programme connected advances in targeted therapies and manufacturing technologies with the practical requirements of containment, occupational safety, product quality and regulatory compliance.

Against the backdrop of growing interest in oncology treatments and antibody-drug conjugates (ADCs), the event addressed the expertise, infrastructure and collaboration needed to support increasingly complex pharmaceutical development and manufacturing.

Two Days of Expertise and Industry Exchange

The programme explored key considerations across HPAPI operations, including:

• Hazard identification, toxicity assessment and exposure risk analysis

• Containment technologies, isolator designs and engineering controls

• Personal protective equipment selection and training

• Occupational exposure limits and exposure control strategies

• Facility layout, airflow and production optimisation

• Cleaning, decontamination and validation

• Workforce training, safety culture and incident response

• Waste management and environmental protection

• Safe storage, transport and supply chain practices

• Global regulatory expectations for HPAPI handling and manufacturing

These topics connected scientific and technical knowledge with the operational decisions required to protect personnel, maintain product quality and support compliant manufacturing.

The programme also considered emerging technologies, including targeted delivery systems and the potential applications of artificial intelligence and machine learning in manufacturing and quality control.

Connecting Innovation with Safe Manufacturing

A central theme of the eighth edition was the relationship between therapeutic innovation and the systems required to manufacture highly potent compounds safely.

The programme examined how risk assessment can inform containment selection, facility design, working practices and exposure controls. Cleaning and decontamination, personnel training and environmental management were addressed as connected elements of an effective approach to HPAPI operations.

Alongside engineering solutions, the summit highlighted the importance of a skilled workforce and a proactive safety culture. Clear procedures, appropriate training and collaboration across development, manufacturing, quality, engineering and occupational safety remain essential to managing the challenges associated with potent compounds.

Creating Opportunities for Professional Connection

Beyond the technical programme, the summit provided opportunities for participants to exchange experiences, discuss shared challenges and build professional connections.

Bringing together perspectives from different areas of HPAPI development and manufacturing supported conversations around practical approaches, technology needs and potential collaboration. These exchanges formed an important part of the event’s role in connecting expertise across the industry.

The eighth edition of the HPAPI Summit highlighted the importance of knowledge sharing, collaboration and effective safety practices in advancing highly potent API development and manufacturing.

From hazard assessment and containment to facility optimisation, workforce training and emerging technologies, the programme reflected the multidisciplinary approach required to support safe and reliable HPAPI operations.

We look forward to continuing these conversations and bringing the community together for future editions.

Thank you to our speakers, moderators, sponsors, partners and attendees for contributing to the 8th HPAPI Summit in Berlin.

Etapa Pharma Team

8th HPAPI: Development and Manufacturing of Highly Potent Active Pharmaceutical Ingredients
Berlin, Germany | 2025